CompletedPhase 2NCT01588405

Remodulin® to Oral Treprostinil Transition

Studying Idiopathic pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
United Therapeutics
Principal Investigator
Cynthia Madden, MD, MPH, RDCS
Senior Clinical Research Physician
Intervention
UT-15C SR(drug)
Enrollment
33 enrolled
Eligibility
15-80 years · All sexes
Timeline
20122014

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01588405 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary arterial hypertension

← Back to all trials